Biologic: Clinical Trials

3 trials for Biologic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 1 Early Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Early Phase 11Completed 1
Phase 31Recruiting 1

Follow Biologic: new trials by email Literature Review of Biologic trials Research Report on Biologic

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
a Prospective, Multicenter, Randomized Controlled Trial, With a Non-randomized Sentinel Cohort, Evaluating the Efficacy of Bioxheal, a Single-layer Placental-derived Biologic in Nonhealing Diabetic Foot Ulcers
Standard of Care, BIOxHEAL (human amniotic membrane allograft) - Diabetic Foot Ulcer, Amniotic Membrane Placental Allograft
Phase 3RecruitingApplied Biologics, LLC2532026-10-082026-10-16
Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo
Tildrakizumab - Skin and Connective Tissue Diseases, Skin Diseases
Early Phase 1CompletedPremier Specialists, Australia122021-09-162024-11-12
Multidisciplinary Integrated Platform for a Technological Innvovative Approach to Oncotherapies
Biologic
CompletedNational Cancer Institute, Naples2692020-03-022024-06-26

Narrower conditions

Diabetic Foot (1)  ·  Hypopigmentation (1)  ·  Pigmentation Disorders (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Vitiligo (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Diabetes Complications (1)  ·  Diabetes Mellitus (1)  ·  Diabetic Angiopathies (1)  ·  Diabetic Neuropathies (1)  ·  Endocrine System Diseases (1)  ·  Foot Ulcer (1)  ·  Leg Ulcer (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Skin Diseases (1)  ·  Skin Ulcer (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Vascular Diseases (1)

Interventions

Standard of Care (1)  ·  tildrakizumab (1)

Sponsors

Applied Biologics, LLC (1)  ·  National Cancer Institute, Naples (1)  ·  Premier Specialists, Australia (1)

Countries

Australia (1)  ·  Italy (1)  ·  United States (1)

Top investigators

Charles Zelen, DPM (1)  ·  Dedee Murrell, MD (1)  ·  Nicola Normanno (1)